Why Successful Companies Are ‘Tough On Themselves’ When It Comes To HTA

Pharmaceutical companies need to “pressure test” their clinical development strategies early for health technology assessment purposes, particularly in light of the new EU HTA Regulation, a life sciences consultant says.

Companies need to pressure test their clinical development strategies in light of the EU HTA Regulation (Shutterstock)
Key Takeaways
  • Companies will need to put more work into their clinical development strategies to succeed at the EU Health Technology Assessment Regulation’s joint clinical assessment process (JCA), a consultant says.

The EU Health Technology Assessment (HTA) Regulation will require companies to “get smart on their own clinical trial development,” according...

More from Interviews

More from R&D